Urokinase-type plasminogen activator receptor transcriptionally controlled adenoviruses eradicate pancreatic tumors and liver metastasis in mouse models.

Huch, Meritxell

Urokinase-type plasminogen activator receptor transcriptionally controlled adenoviruses eradicate pancreatic tumors and liver metastasis in mouse models. [electronic resource] - Neoplasia (New York, N.Y.) Jun 2009 - 518-28, 4 p following 528 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1476-5586

10.1593/neo.81674 doi


Adenoviridae--genetics
Adenovirus E1A Proteins--genetics
Animals
Cell Line
Cell Line, Tumor
Cell Survival
Gene Expression Regulation
Green Fluorescent Proteins--genetics
Humans
Liver--metabolism
Liver Neoplasms, Experimental--secondary
Luciferases--genetics
Male
Mice
Mice, Inbred BALB C
NIH 3T3 Cells
Oncolytic Virotherapy--methods
Oncolytic Viruses--genetics
Pancreatic Neoplasms--pathology
Promoter Regions, Genetic--genetics
Receptors, Urokinase Plasminogen Activator--genetics
Tumor Burden
Xenograft Model Antitumor Assays